ID

41196

Description

Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01266512

Link

https://clinicaltrials.gov/show/NCT01266512

Keywords

Versions (1)
  1. 7/11/20 7/11/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 11, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lung Neoplasms NCT01266512

English

Eligibility Lung Neoplasms NCT01266512

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically proven locally advanced, inoperable, confirmed by pet scan (thorax/
Description

Locally Advanced Inoperable | PET scan chest | PET scan Upper abdomen

Data type

boolean

Alias
UMLS CUI [1,1]
C0205179
UMLS CUI [1,2]
C1517927
UMLS CUI [1,3]
C0205187
UMLS CUI [2]
C2073388
UMLS CUI [3,1]
C0032743
UMLS CUI [3,2]
C2937240
upper abdomen) to be international stage iii (2009) nsclc and without multifocal tumours in the lung
Description

Non-Small Cell Lung Carcinoma TNM clinical staging | Lung Neoplasms Multifocal Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C0024121
UMLS CUI [2,2]
C0205292
UMLS CUI [2,3]
C0332197
disease volume encompassible within a tolerable planning target volume treated to 66 gy
Description

Disease Volume | Planning target volume Tolerable

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0449468
UMLS CUI [2,1]
C0454199
UMLS CUI [2,2]
C4053931
fev1 (force expiratory volume in 1 second) >1000 ml
Description

FEV1

Data type

boolean

Alias
UMLS CUI [1]
C0849974
hemoglobin ≥ 9.0 g/dl
Description

Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0518015
absolute neutrophil count (anc) ≥ 1,500/mm3
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelet count ≥ 100,000/mm3
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
total bilirubin ≥ 1.5 times the upper limit of normal
Description

SERUM TOTAL BILIRUBIN ELEVATED

Data type

boolean

Alias
UMLS CUI [1]
C0595866
alt (alanine aminotransferase) and ast (aspartate transaminase) ≤ 2.5 x upper limit of normal (≤ 5 x upper limit of normal for patients with liver derangement)
Description

Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Deranged liver function tests

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0857338
ecog (eastern cooperative oncology group) ps 0-1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous treatment with chest radiotherapy, chemotherapy or molecularly targeted agents
Description

Radiotherapy to thorax | Chemotherapy | Molecular Targeted Therapy

Data type

boolean

Alias
UMLS CUI [1]
C4038705
UMLS CUI [2]
C0392920
UMLS CUI [3]
C2699893
inadequate lung function (exercise tolerance less than 1 fos/fight of stairs, fev1 < 1 l/sec, or raised pco2)
Description

Lung function testing abnormal | Exercise tolerance test abnormal | FEV1 | PCO2 increased

Data type

boolean

Alias
UMLS CUI [1]
C0476405
UMLS CUI [2]
C0149612
UMLS CUI [3]
C0849974
UMLS CUI [4]
C0858343
history of hypersensitivity or contraindication to the study drugs or pre-medications or products formulated in polysorbate 80
Description

Hypersensitivity Investigational New Drugs | Medical contraindication Investigational New Drugs | Hypersensitivity Premedication | Medical contraindication Premedication | Hypersensitivity Polysorbate 80 products | Medical contraindication Polysorbate 80 products

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0013230
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0033045
UMLS CUI [4,1]
C1301624
UMLS CUI [4,2]
C0033045
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C0032601
UMLS CUI [5,3]
C1254351
UMLS CUI [6,1]
C1301624
UMLS CUI [6,2]
C0032601
UMLS CUI [6,3]
C1254351
pregnant or breast-feeding women, or women with child-bearing potential who are not following an effective method of contraception and/or who are unwilling or unable to be tested for pregnancy (either by serum or urine pregnancy test before study entry
Description

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Absent | Childbearing Potential Serum pregnancy test Unwilling | Childbearing Potential Serum pregnancy test Unable | Childbearing Potential Urine pregnancy test Unwilling | Childbearing Potential Urine pregnancy test Unable

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C3831118
UMLS CUI [4,2]
C0430064
UMLS CUI [4,3]
C0558080
UMLS CUI [5,1]
C3831118
UMLS CUI [5,2]
C0430064
UMLS CUI [5,3]
C1299582
UMLS CUI [6,1]
C3831118
UMLS CUI [6,2]
C0430056
UMLS CUI [6,3]
C0558080
UMLS CUI [7,1]
C3831118
UMLS CUI [7,2]
C0430056
UMLS CUI [7,3]
C1299582
participation in a clinical trial with any investigational drug used and within 30 days prior to study entry
Description

Study Subject Participation Status | Clinical Trial | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
UMLS CUI [3]
C0013230
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Description

Study Subject Participation Status | Considerations Incomplete

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0518609
UMLS CUI [2,2]
C0205257
Back to the top of the page

Similar models

Eligibility Lung Neoplasms NCT01266512

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Locally Advanced Inoperable | PET scan chest | PET scan Upper abdomen
Item
pathologically proven locally advanced, inoperable, confirmed by pet scan (thorax/
boolean
C0205179 (UMLS CUI [1,1])
C1517927 (UMLS CUI [1,2])
C0205187 (UMLS CUI [1,3])
C2073388 (UMLS CUI [2])
C0032743 (UMLS CUI [3,1])
C2937240 (UMLS CUI [3,2])
Non-Small Cell Lung Carcinoma TNM clinical staging | Lung Neoplasms Multifocal Absent
Item
upper abdomen) to be international stage iii (2009) nsclc and without multifocal tumours in the lung
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0024121 (UMLS CUI [2,1])
C0205292 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Disease Volume | Planning target volume Tolerable
Item
disease volume encompassible within a tolerable planning target volume treated to 66 gy
boolean
C0012634 (UMLS CUI [1,1])
C0449468 (UMLS CUI [1,2])
C0454199 (UMLS CUI [2,1])
C4053931 (UMLS CUI [2,2])
FEV1
Item
fev1 (force expiratory volume in 1 second) >1000 ml
boolean
C0849974 (UMLS CUI [1])
Hemoglobin measurement
Item
hemoglobin ≥ 9.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count (anc) ≥ 1,500/mm3
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count ≥ 100,000/mm3
boolean
C0032181 (UMLS CUI [1])
SERUM TOTAL BILIRUBIN ELEVATED
Item
total bilirubin ≥ 1.5 times the upper limit of normal
boolean
C0595866 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Deranged liver function tests
Item
alt (alanine aminotransferase) and ast (aspartate transaminase) ≤ 2.5 x upper limit of normal (≤ 5 x upper limit of normal for patients with liver derangement)
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0857338 (UMLS CUI [3])
ECOG performance status
Item
ecog (eastern cooperative oncology group) ps 0-1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Radiotherapy to thorax | Chemotherapy | Molecular Targeted Therapy
Item
previous treatment with chest radiotherapy, chemotherapy or molecularly targeted agents
boolean
C4038705 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C2699893 (UMLS CUI [3])
Lung function testing abnormal | Exercise tolerance test abnormal | FEV1 | PCO2 increased
Item
inadequate lung function (exercise tolerance less than 1 fos/fight of stairs, fev1 < 1 l/sec, or raised pco2)
boolean
C0476405 (UMLS CUI [1])
C0149612 (UMLS CUI [2])
C0849974 (UMLS CUI [3])
C0858343 (UMLS CUI [4])
Hypersensitivity Investigational New Drugs | Medical contraindication Investigational New Drugs | Hypersensitivity Premedication | Medical contraindication Premedication | Hypersensitivity Polysorbate 80 products | Medical contraindication Polysorbate 80 products
Item
history of hypersensitivity or contraindication to the study drugs or pre-medications or products formulated in polysorbate 80
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0033045 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0033045 (UMLS CUI [4,2])
C0020517 (UMLS CUI [5,1])
C0032601 (UMLS CUI [5,2])
C1254351 (UMLS CUI [5,3])
C1301624 (UMLS CUI [6,1])
C0032601 (UMLS CUI [6,2])
C1254351 (UMLS CUI [6,3])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Absent | Childbearing Potential Serum pregnancy test Unwilling | Childbearing Potential Serum pregnancy test Unable | Childbearing Potential Urine pregnancy test Unwilling | Childbearing Potential Urine pregnancy test Unable
Item
pregnant or breast-feeding women, or women with child-bearing potential who are not following an effective method of contraception and/or who are unwilling or unable to be tested for pregnancy (either by serum or urine pregnancy test before study entry
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C3831118 (UMLS CUI [4,1])
C0430064 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])
C3831118 (UMLS CUI [5,1])
C0430064 (UMLS CUI [5,2])
C1299582 (UMLS CUI [5,3])
C3831118 (UMLS CUI [6,1])
C0430056 (UMLS CUI [6,2])
C0558080 (UMLS CUI [6,3])
C3831118 (UMLS CUI [7,1])
C0430056 (UMLS CUI [7,2])
C1299582 (UMLS CUI [7,3])
Study Subject Participation Status | Clinical Trial | Investigational New Drugs
Item
participation in a clinical trial with any investigational drug used and within 30 days prior to study entry
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
Study Subject Participation Status | Considerations Incomplete
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1])
C0518609 (UMLS CUI [2,1])
C0205257 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial